• Return to Headlines

Anthera Pharmace has the Lowest Sales per Share in the Biotechnology Industry (ANTH, CDTX, VTL, ZFGN, ACHN)

By David Diaz

Below are the three companies in the Biotechnology industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Anthera Pharmace ranks lowest with a sales per share of $0.00. Cidara Therapeut is next with a sales per share of $0.00. Vital Therapies ranks third lowest with a sales per share of $0.00.

Zafgen Inc follows with a sales per share of $0.00, and Achillion Pharma rounds out the bottom five with a sales per share of $0.00.

SmarTrend recommended that subscribers consider buying shares of Achillion Pharma on January 7th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $1.90. Since that recommendation, shares of Achillion Pharma have risen 51.1%. We continue to monitor Achillion Pharma for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest sales per share anthera pharmace cidara therapeut vital therapies zafgen inc achillion pharma

Ticker(s): ANTH CDTX VTL ZFGN ACHN